Oppenheimer Hosts Inaugural Drone Day To Showcase New Technologies

NEW YORK, Sept. 21, 2016

The event featured Shan Phillips, CEO of Yuneec International Co.'s U.S. business, and Gilles Labossiere, CFO of Parrot SA, as keynote speakers. Panelists included Chris Thomas with MultiGP, Todd Wahl with FPVLive.tv and Tim Nilson with Lumenier, who discussed emerging drone racing leagues during lunch. Attendees also had an opportunity for one-on-one meetings with the leading drone and drone technology providers. Other important topics covered included machine vision, cloud infrastructure of drones, integration of drones in enterprise decision making, along with consumer applications for drones.

"Oppenheimer remains committed to providing our clients with the insights they need to wisely invest in the latest technologies," said Erica L. Moffett, Managing Director and Associate Director of Research at Oppenheimer. "Drone Day is the latest addition to a robust calendar of events, following our 19^th Annual Technology Conference last month, designed to further educate our clients about new investment opportunities. We enjoyed using the event to further elevate conversations surrounding drones and bring life to the technology for attendees."

Andrew Uerkwitz, Managing Director and Senior Analyst at Oppenheimer, said, "The openness of our Drone Day venue created a truly unique experience. Demonstrations at similar events often are limited to small spaces unable to fully showcase the technology. Oppenheimer gave clients a chance to see what cutting-edge drone technology can really do to help businesses and consumers alike – something we look forward to continuing each year as the technology advances."

Oppenheimer's next conference, the 2016 Life Sciences Summit, is scheduled for Nov. 29, 2016 in New York City. The event will feature individual meetings with more than 50 emerging life sciences companies across the biotechnology, bio-pharmaceutical, and specialty pharmaceutical sectors. Attendees will have the opportunity to learn about the newest technologies on the market and their potential impacts.

Also coming up is Oppenheimer's 27^th Annual Healthcare Conference in New York City on March 21-22, 2017. The event will feature management teams from more than 100 public and private companies, covering a wide range of topics such as biotechnology, medical devices and healthcare IT. Throughout the conference, investors will have access to key thought leaders addressing issues such as health reform implementation, Medicare and Medicaid policy changes, generic drug regulation, and other topics.

Oppenheimer & Co. Inc.